The native B:9-23 sequence is required for disease initiation in the NOD mouse as mutation of one amino acid (B16Y>A), a key residue for the MHC-II I-Ag7/T cell receptor interaction, protects NOD mice from diabetes, ablates islet infiltration, and prevents development of insulin autoantibodies (34). This evidence concerns the gene INS and diabetes mellitus.